The relationship between epicardial adipose tissue thickness and oxidative stress parameters in patients with isolated polycystic ovary syndrome

References

• Franks S. Polycystic ovary syndrome. N Engl J Med 1995;333:853–61
   PubMed Web of Science ®Google Scholar
• Legro RS, Kunselman AR, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 2001;111:607–13
   PubMed Web of Science ®Google Scholar
• Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:1929–35
   PubMed Web of Science ®Google Scholar
• Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 2003;552:335–44
   PubMed Web of Science ®Google Scholar
• Tarin JJ, Brines J, Cano A. Antioxidants may protect against infertility. Hum Reprod 1998;13:1415–16
   PubMed Web of Science ®Google Scholar
• Dahlgren E, Janson PO, Johansson S, et al. Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 1992;71:599–604
   PubMed Web of Science ®Google Scholar
• Paradisi G, Steinberg HO, Hempfling A, et al. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 2001;103:1410–15
   PubMed Web of Science ®Google Scholar
• Sabuncu T, Vural H, Harma M, Harma M. Oxidative stress in polycystic ovary syn-drome and its contribution to the risk of cardiovascular disease. Clin Biochem 2001;34:407–13
   PubMed Web of Science ®Google Scholar
• Fenkci V, Fenkci S, Yilmazer M, Serteser M. Decreased total antioxidant status and in-creased oxidative stress in women with poly-cystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril 2003;80:123–7
   PubMed Web of Science ®Google Scholar
• Dincer Y, Akcay T, Erdem T, et al. DNA damage, DNA susceptibility to oxidation and glutathione level in women with polycystic ovary syndrome. Scand J Clin Lab Invest 2005;65:721–8
   PubMed Web of Science ®Google Scholar
• Verit FF, Erel O. Oxidative stress in nonobese women with polycystic ovary syndrome: correlations with endocrine and screening parameters. Gynecol Obstet Invest 2008;65:233–9
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term healthy risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25
   Web of Science ®Google Scholar
• Ferriman D, Gallway JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440–7
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and b cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–19
   PubMed Web of Science ®Google Scholar
• Belli SH, Graffigna MN, Oneta A, et al. Effect of rosiglitazone on insulin resistance, growht factors, and reproductive disturbances in women with polycystic ovary syndrome. Fertil Steril 2004;81:624–9
   PubMed Web of Science ®Google Scholar
• Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103–11
   PubMed Web of Science ®Google Scholar
• Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112–19
   PubMed Web of Science ®Google Scholar
• Kishida K, Funahashi T, Matsuzawa Y, Shimomura I. Visceral adiposity as a target for the management of the metabolic syndrome. Ann Med 2012;44:233–41
   PubMed Web of Science ®Google Scholar
• Cobin RH. Cardiovascular and metabolic risks associated with PCOS. Intern Emerg Med 2013;8:S61–4
   PubMed Web of Science ®Google Scholar
• Cakir E, Doğan M, Topaloglu O, et al. Subclinical atherosclerosis and hyperandrogenemia are independent risk factors for increased epicardial fat thickness in patients with PCOS and idiopathic hirsutism. Atherosclerosis 2013;226:291–5
   PubMed Web of Science ®Google Scholar
• Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003;108: 2460–66
   PubMed Web of Science ®Google Scholar
• National, Cholestrol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholestrol in Adults (Adult Treatment Panel III). Third Report of the National Cholestrol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholestrol in Adults (Adult treatment Panel III) final report. Circulation 2002;106:3143–31
   PubMed Web of Science ®Google Scholar
• Tsai-Turton M, Luderer U. Opposing effects of glutathione depletion and follicle-stimulating hormone on reactive oxygen species and apoptosis in cultured preovulatory rat follicles. Endocrinology 2006;147:1224–36
   PubMed Web of Science ®Google Scholar
• Murray AA, Molinek MD, Baker SJ, et al. Role of ascorbic acid in promoting follicle integrity and survival in intact mouse ovarian follicles in vitro. Reproduction 2001;121:89–96
   PubMed Web of Science ®Google Scholar
• Otala M, Erkkilä K, Tuuri T, et al. Cell death and its suppression in human ovarian tissue culture. Mol Hum Reprod 2002;8:228–36
   PubMed Web of Science ®Google Scholar
• Murri M, Luque-Ramírez M, Insenser M, et al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update 2013;19:268–88
   PubMed Web of Science ®Google Scholar
• Kelly CC, Lyall H, Petrie JR, et al. Low-grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 2001;86:2453–5
   PubMed Web of Science ®Google Scholar
• Benson S, Janssen, OE, Hahn S, et al. Obesity, depression and chronic lowgrade inflammation in women with polycystic ovary syndrome. Brain Behav Immun 2008;22:177–84
   PubMed Web of Science ®Google Scholar
• Zhao YF, Feng DD, Chen C. Contribution of adipocyte-derived factors to beta cell dysfunction in diabetes. Int J Biochem Cell Biol 2006;38:804–19
   PubMed Web of Science ®Google Scholar
• Randeva HS, Tan BK, Weickert MO, et al. Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev 2012;33:812–41
   PubMed Web of Science ®Google Scholar
• Panidis D, Tziomalos K, Misichronis G, et al. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Hum Reprod 2012;27:541–9
   PubMed Web of Science ®Google Scholar
• Morales AJ, Laughlin GA, Bützow T, et al. Insulin, somatotropic, and luteinizinghormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab 1996;81:2854–64
   PubMed Web of Science ®Google Scholar
• Singh B, Saxena A. Surrogate markers of insulin resistance: a review. World J Diabetes. 2010;1:36–47
   PubMedGoogle Scholar